Clinical Trials Logo

Filter by:
NCT ID: NCT00163644 Active, not recruiting - Clinical trials for Hematological Malignancies

RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMT

Start date: November 2003
Phase: N/A
Study type: Interventional

The hypothesis is that exercise will improve the physical performance and quality of life of bone marrow/ haemopoietic stem cell transplants.The aim of the trial is to provide definite clinical evidence as to which( if any) type of exercise is most beneficial for this patient population. It is also aimed at improving the provision of physiotherapy services to this group of patients.

NCT ID: NCT00163631 Completed - Portal Hypertension Clinical Trials

Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

Start date: n/a
Phase: N/A
Study type: Observational

Investigate vasoactive medicators in portal hypertension on stored sera

NCT ID: NCT00163553 Recruiting - Sciatica Clinical Trials

Neuraxial Pethidine After Lumbar Surgery Trial

Start date: December 2004
Phase: Phase 3
Study type: Interventional

The hypothesis is that epidural pethidine is an effective form of pain relief following lumbar spinal surgery, resulting in significantly lower usage of concomitantly administered (intravenous) patient-controlled analgesia (PCA) pethidine.

NCT ID: NCT00163475 Completed - Asthma Clinical Trials

Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)

Start date: May 2004
Phase: Phase 3
Study type: Interventional

Bronchial asthma is among the world's most prevalent diseases. Roflumilast is a novel, orally active, selective enzyme inhibitor (phosphodiesterase 4 inhibitor), which has shown effectiveness in the treatment of asthma. The aim of the study is to compare the effect of roflumilast on lung function, symptoms, and use of rescue medication in patients with stable asthma. Roflumilast will be administered orally either in the morning or in the evening at one dose level. The study duration consists of a baseline period (1 to 2 weeks) and a treatment period (6 weeks). The study will provide further data on safety, tolerability, and effectiveness of roflumilast.

NCT ID: NCT00163358 Completed - Asthma Clinical Trials

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

Start date: September 2003
Phase: Phase 3
Study type: Interventional

The aim of the study is to compare the efficacy of ciclesonide versus fixed combination of fluticasone propionate/salmeterol versus placebo, on long-term asthma control in patients with mild persistent asthma. The study duration consists of a baseline period (2 weeks) and a treatment period (12 months). The study will provide further data on safety and tolerability of ciclesonide.

NCT ID: NCT00163098 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD

Start date: December 2004
Phase: Phase 1/Phase 2
Study type: Interventional

A randomised, controlled study investigating the effect of UK-369,003 on exercise tolerance in patients with COPD

NCT ID: NCT00162266 Completed - Clinical trials for Rheumatoid Arthritis

Abatacept With Methotrexate- Phase IIB

Start date: October 2000
Phase: Phase 2
Study type: Interventional

This study was conducted to assess the safety and tolerability of Abatacept combined with Methotrexate in participants with active rheumatoid arthritis (RA). The secondary objectives were to assess efficacy, pharmacodynamic marker activity, and immunogenicity of Abatacept combined with Methotrexate.

NCT ID: NCT00162240 Completed - Diabetes Mellitus Clinical Trials

PPAR - Combination With Metformin

Start date: June 2003
Phase: Phase 3
Study type: Interventional

A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination with Metformin Therapy in Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

NCT ID: NCT00162175 Completed - Clinical trials for Metabolics Diabetes Nos

PPAR-COMBO With Sulfonylurea

Start date: July 2003
Phase: Phase 3
Study type: Interventional

A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination with Glyburide Therapy in Subjects with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sulfonylurea Therapy Alone.

NCT ID: NCT00160706 Completed - Crohn's Disease Clinical Trials

A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease

PRECiSE 4
Start date: February 2004
Phase: Phase 3
Study type: Interventional

A follow-on safety study in subjects with Crohn's Disease who have previously been withdrawn from the double-blind study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] due to an exacerbation of Crohn's Disease.